Literature DB >> 7476937

The role of tau phosphorylation in transfected COS-1 cells.

M Medina1, E Montejo de Garcini, J Avila.   

Abstract

Tau cDNAs from each of the six human isoforms were transfected into COS-1 cells and, in every case, more than one peptide was observed. The diversity of expressed isoforms was due to different levels of tau phosphorylation. Tau phosphorylation results in a decrease of the protein electrophoretic mobility. The major contribution to this mobility shift is due to the phosphorylation at the at the C-terminus of the molecule, as inferred from the expression of tau fragments. Phosphorylation takes place in some of the sites modified in neural cells and in the basis of AD patients. Copolymerization studies indicate that the level of phosphorylation, as well as the localization of the modified residues, may affect the binding of the protein to microtubules. These results indicate that phosphorylation regulates tau function inside the cell.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7476937     DOI: 10.1007/bf00929506

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  58 in total

1.  Microtubule-associated protein tau is phosphorylated by protein kinase C on its tubulin binding domain.

Authors:  I Correas; J Díaz-Nido; J Avila
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.157

2.  Self assembly of microtubule associated protein tau into filaments resembling those found in Alzheimer disease.

Authors:  E Montejo de Garcini; L Serrano; J Avila
Journal:  Biochem Biophys Res Commun       Date:  1986-12-15       Impact factor: 3.575

3.  The microtubule binding domain of tau protein.

Authors:  G Lee; R L Neve; K S Kosik
Journal:  Neuron       Date:  1989-06       Impact factor: 17.173

4.  Microtubule assembly in the absence of added nucleotides.

Authors:  M L Shelanski; F Gaskin; C R Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

5.  Solubility properties of neuronal tubulin: evidence for labile and stable microtubules.

Authors:  M M Black; J M Cochran; J T Kurdyla
Journal:  Brain Res       Date:  1984-03-19       Impact factor: 3.252

6.  Overexpression of tau protein in COS-1 cells results in the stabilization of centrosome-independent microtubules and extension of cytoplasmic processes.

Authors:  E Montejo de Garcini; S de la Luna; J E Dominguez; J Avila
Journal:  Mol Cell Biochem       Date:  1994-01-26       Impact factor: 3.396

7.  Tau-related protein present in paired helical filaments has a decreased tubulin binding capacity as compared with microtubule-associated protein tau.

Authors:  A Nieto; I Correas; C López-Otín; J Avila
Journal:  Biochim Biophys Acta       Date:  1991-04-15

8.  Solubilization and fractionation of paired helical filaments.

Authors:  P J González; I Correas; J Avila
Journal:  Neuroscience       Date:  1992-09       Impact factor: 3.590

9.  Expression of tau protein in non-neuronal cells: microtubule binding and stabilization.

Authors:  G Lee; S L Rook
Journal:  J Cell Sci       Date:  1992-06       Impact factor: 5.285

10.  Tau protein function in living cells.

Authors:  D G Drubin; M W Kirschner
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  10 in total

1.  Tau dephosphorylation at tau-1 site correlates with its association to cell membrane.

Authors:  M Arrasate; M Pérez; J Avila
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

2.  Role of glycosaminoglycans in determining the helicity of paired helical filaments.

Authors:  M Arrasate; M Pérez; J M Valpuesta; J Avila
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

3.  Phosphorylation of stathmin modulates its function as a microtubule depolymerizing factor.

Authors:  F J Moreno; J Avila
Journal:  Mol Cell Biochem       Date:  1998-06       Impact factor: 3.396

4.  Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymers.

Authors:  Ismael Santa-María; Félix Hernández; Mark A Smith; George Perry; Jesús Avila; Francisco J Moreno
Journal:  Mol Cell Biochem       Date:  2005-10       Impact factor: 3.396

5.  Glycogen synthase kinase 3 phosphorylation of different residues in the presence of different factors: analysis on tau protein.

Authors:  F J Moreno; J R Muñoz-Montaño; J Avila
Journal:  Mol Cell Biochem       Date:  1996-12-06       Impact factor: 3.396

6.  Specific Peptide from the Novel W-Tau Isoform Inhibits Tau and Amyloid β Peptide Aggregation In Vitro.

Authors:  Raquel Cuadros; Mar Pérez; Daniel Ruiz-Gabarre; Félix Hernández; Vega García-Escudero; Jesús Avila
Journal:  ACS Chem Neurosci       Date:  2022-06-13       Impact factor: 5.780

7.  Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy.

Authors:  M Pérez; J M Valpuesta; E M de Garcini; C Quintana; M Arrasate; J L López Carrascosa; A Rábano; J García de Yébenes; J Avila
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

8.  Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.

Authors:  Mitul Sarkar; Jeff Kuret; Gloria Lee
Journal:  J Neurosci Res       Date:  2008-09       Impact factor: 4.164

9.  Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease.

Authors:  J P Brion; G Tremp; J N Octave
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

Review 10.  Use of okadaic acid to identify relevant phosphoepitopes in pathology: a focus on neurodegeneration.

Authors:  Miguel Medina; Jesús Avila; Nieves Villanueva
Journal:  Mar Drugs       Date:  2013-05-21       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.